[PODCAST] Ep 55: What You Need to Know about Liquid Biopsy

Learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!

Five years ago, the FDA approved the first liquid biopsy test for use in patients with cancer, providing cancer teams and patients a less invasive and more efficient way to detect disease. But liquid biopsies aren’t cheap, and reimbursement for them can be unpredictable and confusing.

On this episode of CANCER BUZZ, learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.

Guests:

  • J. Nicholas Bodor, MD, PhD, MPH, Assistant Professor, Department of Hematology/Oncology, Fox Chase Cancer Center
  • Kathryn A. Phillips, PhD, Professor of Health Economics and Health Services Research; Director, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco

Related Content:

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington